<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Yonsei Med J</journal-id>
      <journal-id journal-id-type="publisher-id">YMJ</journal-id>
      <journal-title-group>
        <journal-title>Yonsei Medical Journal</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0513-5796</issn>
      <issn pub-type="epub">1976-2437</issn>
      <publisher>
        <publisher-name>Yonsei University College of Medicine</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">21155028</article-id>
      <article-id pub-id-type="pmc">3017683</article-id>
      <article-id pub-id-type="doi">10.3349/ymj.2011.52.1.1</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Review Article</subject>
          <subj-group>
            <subject>Anesthesiology</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Case Report and Mini Literature Review: Anesthetic Management for Severe Peripartum Cardiomyopathy Complicated with Preeclampsia Using Sufetanil in Combined Spinal Epidural Anesthesia</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Bhakta</surname>
            <given-names>Pradipta</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Mishra</surname>
            <given-names>Pragnyadipta</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bakshi</surname>
            <given-names>Anamika</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Langer</surname>
            <given-names>Vijay</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Anesthesiology, Sultan Quaboos University Hospital, Muscat, Sultanate of Oman.</aff>
      <aff id="A2"><label>2</label>Department of Anesthesiology, University of Florida College of Medicine-Jacksonville, Fl, USA.</aff>
      <aff id="A3"><label>3</label>Department of Anesthesiology, Moolchand Hospital, New Delhi, India.</aff>
      <author-notes>
        <corresp>
Corresponding author: Dr. Pragnyadipta Mishra, Clinical Lecturer, Department of Anesthesiology, University of Florida College of Medicine-Jacksonville, 655 W 8th Street, Jacksonville, FL 32209, USA. Tel: 904-244-4195, Fax: 904-244-4908, <email>pragyandeep@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <day>01</day>
        <month>1</month>
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>30</day>
        <month>11</month>
        <year>2010</year>
      </pub-date>
      <volume>52</volume>
      <issue>1</issue>
      <fpage>1</fpage>
      <lpage>12</lpage>
      <history>
        <date date-type="received">
          <day>30</day>
          <month>12</month>
          <year>2009</year>
        </date>
        <date date-type="rev-recd">
          <day>11</day>
          <month>5</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>11</day>
          <month>5</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Copyright: Yonsei University College of Medicine 2011</copyright-statement>
        <copyright-year>2011</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">http://creativecommons.org/licenses/by-nc/3.0</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Peripartum cardiomyopathy (PPCM) is a rare entity, and anesthetic management for cesarean section of a patient with this condition can be challenging. We hereby present the anesthetic management of a patient with PPCM complicated with preeclampsia scheduled for cesarean section, along with a mini review of literature. A 24 year-old primigravida with twin gestation was admitted to our hospital with severe PPCM and preeclampsia for peripartum care, which finally required a cesarean section. Preoperative optimization was done according to the goal of managing left ventricular failure. Combined spinal epidural (CSE) anaesthesia with bupivacaine and sufentanil was used for cesarean section under optimal monitoring. The surgery was completed without event or complication. Postoperative pain relief was adequate and patient required only one epidural top up with sufentanil 6 hours after operation. To the best of our knowledge there is no report in literature of the use of sufentanil as a neuraxial opioid in the anesthetic management of cesarean section in a patient with PPCM. CSE with sufentanil may be a safer and more effective alternative in such cases.</p>
      </abstract>
      <kwd-group>
        <kwd>Peripartum cardiomyopathy</kwd>
        <kwd>anesthetic management</kwd>
        <kwd>combined spinal epidural</kwd>
        <kwd>sufentanil</kwd>
        <kwd>literature review</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Peripartum cardiomyopathy (PPCM) is by definition a primary myocardial disease without any demonstrable cause and having onset during the last month of pregnancy or in the first five months after delivery.<xref ref-type="bibr" rid="B1">1</xref> Echocardiographic features of left ventricular dysfunction were added to the modified definition later to make it more precise (<xref ref-type="table" rid="T1">Table 1</xref>).<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B3">3</xref> PPCM may be associated with preeclampsia and the clinical scenario can worsen heart failure.<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B4">4</xref>-<xref ref-type="bibr" rid="B20">20</xref> Anesthetic management of cesarean section in PPCM patients can be a challenge to the anesthesiologist.<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref> Correct choice of anesthesia and precise titration is crucial for a favorable outcome. We present the anesthetic management of such a patient along with a small relevant literature review.</p>
    </sec>
    <sec sec-type="cases">
      <title>CASE REPORT</title>
      <p>A twenty-four year-old primigravida weighing fifty kilogram (kg) was admitted to a cardiac center at thirty-two weeks of gestation with complaints of increasing breathlessness and generalized swelling for two weeks without any prior coexisting medical illnesses. She was diagnosed with peripartum cardiomyopathy complicated with preeclampsia based on clinical and echocardiographic findings (<xref ref-type="table" rid="T2">Table 2</xref>) and was put on oral digoxin 0.25 mg (five days a week), furosemide 40 mg once daily, carvedilol 3.125 mg twice daily and potassium supplements. She was referred to our hospital for further management.</p>
      <p>Treatment was started in the intensive care unit by a multidisciplinary team of physicians with a plan to control her heart failure medically and to induce fetal lung maturation by dexamethasone before elective delivery.<xref ref-type="bibr" rid="B12">12</xref> Because of intrauterine death (IUD) of one fetus (as revealed by repeat ultrasonogram) and progressive deterioration of cardiac status and liver function tests (LFT) (<xref ref-type="table" rid="T3">Table 3</xref>), a decision was made to electively terminate the pregnancy by cesarean section.</p>
      <p>Preanaesthetic examination revealed pulse rate (PR), blood pressure (BP), peripheral oxygen saturation (SpO<sub>2</sub>) and respiratory rate of 80 beats/min, 90/70 mmHg, 90% on room air and 15/min, respectively. The chest was found to be clear on auscultation. Examination of the cardiovascular system (CVS) showed a third heart sound and an ejection systolic murmur in the mitral area. The preoperative echocardiogram showed dilated cardiac chambers, global hypokinesia with a left ventricular ejection fraction (LVEF) of 25% and moderate pulmonary arterial hypertension (PAH) (<xref ref-type="table" rid="T2">Table 2</xref>). Significant laboratory investigations were borderline derangement in LFT, coagulation parameters, marginal leucocytosis and platelet count of 98 &#xD7; 10<sup>9</sup>/L (<xref ref-type="table" rid="T3">Table 3</xref>). The anesthetic plan of performing the procedure under combined spinal epidural (CSE) after optimization of cardiovascular and coagulation status was discussed with the parent team and the patient, who gave informed consent.</p>
      <p>The preoperative optimization process was initiated. Invasive arterial and central venous accesses were established. Dopamine and dobutamine infusions were started and titrated to optimize her cardiovascular variables. She received fresh frozen plasma (FFP) for correction of her coagulation status. Intravenous ranitidine (50 mg) and metoclopramide (10 mg) and oral sodium citrate solution (0.3 M, 30 mL) were given 30 minutes before transferring her to the operating room (OR). Standard ASA monitors along with invasive blood pressure (IBP), central venous pressure (CVP) and urine output were used for intraoperative monitoring. Oxygen was administered via facemask at 4 L/min. Her preoperative heart rate (HR), mean arterial pressure (MAP), CVP, and SpO<sub>2</sub> were 108/min, 65 mmHg, 15 mmHg and 94%.</p>
      <p>The CSE technique consisted of sitting position and midline approach at L3-L4 interspace. The epidural space was identified by loss of resistance to saline on the first attempt with an 18G Tuohy needle (Portex). A subarachnoid block (SAB) was done by 27G Whitacre needle by needle through needle technique and 1.2 mL of 0.5% heavy bupivacaine (6 mg) with 7.5 &#xB5;g of sufentanil was injected after free flow of cerebrospinal fluid (CSF). An 18 gauge epidural catheter (EC) was threaded up to the length of four cm into epidural space. A fifteen cm wedge was placed under the left hip to maintain a left lateral tilt. Level of block (response to ice cube) was checked at 3, 5 and 10 minutes and was found to be up to thoracic 10th, 8th, 6th segment level respectively. Effective onset of block resulted in some improvement of MAP, SpO<sub>2</sub> and clinical symptoms. Surgery went ahead without event and both the living baby and dead fetus were delivered. Apgar scores of the baby at 1 and 5 minutes were 7 and 9 respectively. Intravenous oxytocin drip (15 units/500 mL of saline at 40 drops/min) was started slowly after delivery. Intravenous furosemide 10 mg and midazolam 2 mg were given incrementally at this time. Dopamine and dobutamine infusions were continued throughout the surgery titrated to the hemodynamics. The total estimated blood loss was about 250 mL during the hour-long procedure. Intravenous fluid replacement was targeted to maintain the CVP of 12 to 14 mmHg, and 750 mL of Ringer's Lactate (RL) was given intraoperatively. Urine output was 75 mL without any episode of adverse hemodynamic events. Intraoperative parameters like heart rate (HR), mean arterial pressure (MAP), CVP and SpO<sub>2</sub> remained within 20% of the preoperative value.</p>
      <p>The patient was transferred back to the ICU after the procedure. She remained absolutely pain free for the next six hours and the EC was removed after administration of 20 &#xB5;g of sufentanil in 10 mL NS. Furosemide and digoxin were restarted and FFP transfusion was continued q6h for a day with close monitoring of coagulation profile. Clinical improvement was evident from post-operative day (POD) 2, with a decrease in ionotrope requirement and an improvement in LFT. Patient had mild dyspnea on POD 3 and a chest radiograph showed signs of pulmonary edema, which was relieved by furosemide. Gradually she was weaned off dobutamine completely and restarted on carvedilol. Oral captopril 6.25 mg, spironolactone 25 mg once daily and DVT prophylaxis with 5,000 U unfractionated heparin were added on POD 4. The remainder of her postoperative stay was uneventful. Her LFT, serum creatinine, and uric acid levels showed a decreasing trend corresponding with her improved clinical condition (<xref ref-type="table" rid="T3">Table 3</xref>). Repeat echocardiography on POD 6 showed severe generalized left and right ventricular hypokinesia with further reduction in ejection fraction to less than 25% (<xref ref-type="table" rid="T2">Table 2</xref>).</p>
      <p>She was later transferred back to the cardiac center, where she underwent placement of temporary pacemaker for resistant bradyarrhythmia with some symptomatic improvement without any change in echocardiographic findings. As per the latest verbal information from cardiac center, she continues to have features of moderate ventricular dysfunction while the baby is doing fine. She was strongly advised against any future pregnancies.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>PPCM is a severe form of heart failure which was first described by Demakis and Rahimtoola<xref ref-type="bibr" rid="B1">1</xref> comprising of 3 criteria; namely, 1) Development of heart failure in the last month of pregnancy or within the first 5 months of postpartum, 2) Absence of any determinable cause of cardiac failure and/or 3) Any prior demonstrable heart disease. Later, echocardiographic evidence of left ventricular dysfunction was added by the PPCM workshop committee of the National Institute of Health (NIH) (<xref ref-type="table" rid="T1">Table 1</xref>).<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B3">3</xref> The time period in the definition was specified to exclude congenital and acquired causes of heart failure which may as well be present in the earlier stages of pregnancy although some cases of PPCM have been re-ported to occur outside this time limit.<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B7">7</xref>-<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B21">21</xref>-<xref ref-type="bibr" rid="B27">27</xref> Although the earlier reported incidence was 1 in every 3,000 to 15,000 live births,<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref> more recently reported incidence in the USA was about 1 in every 1,485-4,000 pregnancies, thus indicating an increasing trend, and even more so in African-Americans.<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B14">14</xref>-<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B28">28</xref>-<xref ref-type="bibr" rid="B32">32</xref> This increased incidence may be due to better health awareness and improved diagnostic modalities.<xref ref-type="bibr" rid="B27">27</xref> But PPCM appears to occur more frequently in Haiti (1 in 300 live births)<xref ref-type="bibr" rid="B25">25</xref> and in Africa (1 in 100 to 1,000 live births).<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B25">25</xref> A proper explanation for this much higher incidence of PPCM in some geographic areas is not yet known. Environmental or genetic factors, local cultural habits and re-porting, as well as diagnostic bias, may be some reasons for this higher incidence.<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B18">18</xref>-<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B32">32</xref>-<xref ref-type="bibr" rid="B34">34</xref></p>
      <p>Several risk factors that have been correlated to PPCM are: advanced maternal age, multiparity, multiple gestation, black race, African-American female, malnutrition, hypertension, preeclampsia, alcohol, cocaine and tobacco abuse, poor antenatal care, low socioeconomic condition, breast feeding and positive family history.<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B13">13</xref>-<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B25">25</xref>-<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B32">32</xref>,<xref ref-type="bibr" rid="B35">35</xref>-<xref ref-type="bibr" rid="B40">40</xref> Although PPCM has been reported to occur classically in cases with higher maternal age, parity and African race;<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B32">32</xref>,<xref ref-type="bibr" rid="B36">36</xref>-<xref ref-type="bibr" rid="B39">39</xref>,<xref ref-type="bibr" rid="B41">41</xref> recently it has been found to occur increasingly in younger age groups, and in primigravida and white mothers as well.<xref ref-type="bibr" rid="B5">5</xref>-<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B32">32</xref>,<xref ref-type="bibr" rid="B35">35</xref>,<xref ref-type="bibr" rid="B41">41</xref>-<xref ref-type="bibr" rid="B46">46</xref> Most of the researchers agree that PPCM commonly occurs in twin pregnancies.<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B37">37</xref> Preeclampsia and hypertension has been frequently reported to be associated with PPCM cases.<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B4">4</xref>-<xref ref-type="bibr" rid="B20">20</xref> The similarities in immunopathologic process involving prolactin, matrix-metalloproteinase (MMP) and graft vs. host reaction between preeclampsia and PPCM strongly support this association.<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B47">47</xref>-<xref ref-type="bibr" rid="B49">49</xref> Some authors even described it as a hypertensive heart failure and described it as a significant risk factor for PPCM.<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B44">44</xref> Initially, breast feeding, malnutrition, poor socioeconomic condition and antenatal care were implicated as risk factors;<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B38">38</xref> however, no such correlations have been found in recent reports.<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B37">37</xref> Likewise, although substance abuse and familial occurrence have been causally implicated,<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B37">37</xref> they should be regarded as a variety of cardiomyopathy.<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B8">8</xref> All the reported risk factors are quite old, predating modified definition and echocardiography. Thus, further evaluation will be neces-sary, keeping in mind advances in medical technology.<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B10">10</xref></p>
      <p>Proper etiology of PPCM is unclear and several etiologies such as inflammation (myocarditis, cytokines), viral infection, autoimmunity, abnormal response to the hemodynamic stress of pregnancy, cytokine-mediated inflammation, Gq-related myocyte apoptosis, oxidative stress-induced Cathepsin D production which produces defective prolactin leading to endothelial damage and apoptosis of vascular cells, prolonged tocolysis, and selenium deficiency have been proposed.<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B28">28</xref>-<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B33">33</xref>,<xref ref-type="bibr" rid="B35">35</xref>-<xref ref-type="bibr" rid="B38">38</xref>,<xref ref-type="bibr" rid="B40">40</xref>,<xref ref-type="bibr" rid="B46">46</xref>-<xref ref-type="bibr" rid="B52">52</xref> There is stronger literary evidence to support inflammation, viral infection, 16 kDa prolactin induced apoptosis and autoimmunity as possible etiology of PPCM.<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B29">29</xref>-<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B33">33</xref>,<xref ref-type="bibr" rid="B34">34</xref>,<xref ref-type="bibr" rid="B36">36</xref>,<xref ref-type="bibr" rid="B37">37</xref>,<xref ref-type="bibr" rid="B46">46</xref>-<xref ref-type="bibr" rid="B52">52</xref> Thus, it is more likely that etiology is multifactorial.<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B33">33</xref> New targeted research directing towards inflammatory, viral, prolactin and autoimmune etiologies are needed using modern molecular and biochemical techniques to find out actual reason behind PPCM.<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B37">37</xref></p>
      <p>PPCM clinically presents with orthopnea, dyspnea upon exertion, palpitation, chest pain, headache, cough and malaise suggestive of left ventricular failure.<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B21">21</xref>-<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B36">36</xref>,<xref ref-type="bibr" rid="B39">39</xref>-<xref ref-type="bibr" rid="B42">42</xref>,<xref ref-type="bibr" rid="B45">45</xref> The majority of patients present with severe heart failure [New York Heart Association (NYHA) physical class III or IV].<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B34">34</xref>,<xref ref-type="bibr" rid="B36">36</xref> However, the actual categorization used by NYHA in advanced pregnancy can be confounded by the physiological changes of pregnancy.<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B31">31</xref> Ventricular and supraventricular tachyarrhythmias, intracardiac thrombi, features of systemic embolism such as chest pain, haemoptysis and hemiplegia due to acute myocardial infarction, pulmonary and cerebral embolism, infarction of the spleen and kidney, mesenteric artery occlusion, limb gangrene, and finally multiorgan failure have all been reported as either as presenting symptoms or complications of PPCM.<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B4">4</xref>-<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B34">34</xref>,<xref ref-type="bibr" rid="B37">37</xref>,<xref ref-type="bibr" rid="B39">39</xref>,<xref ref-type="bibr" rid="B42">42</xref></p>
      <p>PPCM is a diagnosis of exclusion after ruling out other common causes of heart failure, such as toxic, metabolic, ischaemic or valvular heart diseases.<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B40">40</xref> Early diagnosis of PPCM is difficult because of physiologic changes of advanced pregnancy.<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B37">37</xref> Certain complications of pregnancy such as anemia, toxemia and amniotic fluid embolism may have similar clinical presentation.<xref ref-type="bibr" rid="B5">5</xref> However, PPCM usually presents in postpartum period (72-93%) when physiologic changes of pregnancy should be normalizing.<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B17">17</xref>-<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B34">34</xref>,<xref ref-type="bibr" rid="B40">40</xref> Thus, if a patient presents with persistent or worsening congestive heart failure especially in puerperium, the possibility of PPCM should always be considered as delay in diagnosis is often associated with increased morbidity and mortality.<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B30">30</xref> A few asymptomatic cases of PPCM have also been reported.<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B39">39</xref> Routine investigations done to confirm the diagnosis are ECG, chest X-ray (CXR), and Doppler echocardiography.<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B30">30</xref> ECG usually shows sinus tachycardia, low voltage complexes, ST-T changes, conduction defects, left axis deviation and ventricular hypertrophy.<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B21">21</xref>-<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B34">34</xref>,<xref ref-type="bibr" rid="B39">39</xref> Other arrhythmias such as supraventricular, ventricular extrasystoles, and ventricular tachycardia may occur.<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B34">34</xref>,<xref ref-type="bibr" rid="B37">37</xref>,<xref ref-type="bibr" rid="B39">39</xref>,<xref ref-type="bibr" rid="B42">42</xref> Common CXR findings are cardiomegaly, pulmonary edema and pleural effusion.<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B21">21</xref>-<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B39">39</xref>,<xref ref-type="bibr" rid="B41">41</xref> As CXR features are nonspecific, routine use of X-ray should be discouraged during pregnancy.<xref ref-type="bibr" rid="B40">40</xref> However, absolutely normal ECG and CXR have been reported.<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B29">29</xref> This makes echocardiography the most valuable and confirmatory diagnostic tool.<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B27">27</xref> Patients may present features of severe ventricular dysfunction such as increased left ventricular end diastolic diameter (LVEDD), left ventricular end systolic diameter (LVESD), decreased left ventricular fractional shortening (LVFS) and LVEF, right ventricular dysfunction, valvular regurgitation, regional wall motion abnormality, pulmonary arterial hypertension (PAH) as well as intra cardiac thrombi.<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B7">7</xref>-<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B21">21</xref>-<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B35">35</xref>,<xref ref-type="bibr" rid="B36">36</xref>,<xref ref-type="bibr" rid="B39">39</xref>,<xref ref-type="bibr" rid="B41">41</xref>-<xref ref-type="bibr" rid="B44">44</xref> Valvular regurgitant lesions are the consequence of cardiac dilatation.<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B26">26</xref> Magnetic resonance imaging (MRI) and computerized topographic scans are more sensitive diagnostic tools for detection of cardiac thrombus.<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B10">10</xref> Cardiac MRI has become an attractive modality to assess cardiac function and to distinguish etiologic nature of PPCM.<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B53">53</xref>,<xref ref-type="bibr" rid="B54">54</xref> Delayed gadolinium enhancement (DGE) can help to detect inflammatory myocarditis and should be used in patients who do not respond to standard heart failure management.<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B54">54</xref> The detection of DGE in order to detect myocardial fibrosis has been indicated as a good prognostic factor.<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B53">53</xref> Cine MRI can be used as an alternative to detect all the pa-rameters like echocardiography.<xref ref-type="bibr" rid="B54">54</xref> Currently, routine use of endomyocardial biopsy is somewhat controversial.<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B37">37</xref> It may be considered if the patient does not improve after two weeks of conventional management.<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B37">37</xref> Routine haematological, biochemical, serological and blood culture studies are used to rule out other causes of heart failure.<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B23">23</xref> Polymerase chain reaction and immunohistochemistry techniques should be used to rule out viral and autoimmune etiology in suspected cases.<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B34">34</xref> Estimation of C-reactive protein (CRP), Interleukin-6 (IL-6), tumor necrosis factor-&#x3B1; (TNF-&#x3B1;), Fas-Apo-1, interferon-&#x3B3; (IFN-&#x3B3;), and N-terminal-pro Brain natriuretic peptide (NT-proBNP, a serum marker of heart failure), serum prolactin should now be strongly considered in light of current evidence of the inflammatory and autoimmune nature of PPCM.<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B36">36</xref>,<xref ref-type="bibr" rid="B46">46</xref>,<xref ref-type="bibr" rid="B49">49</xref>,<xref ref-type="bibr" rid="B52">52</xref></p>
      <p>Medical therapy for PPCM follows the routine principles of management of heart failure and is aimed at reduction of preload, afterload and increase in cardiac contractility through judicious use of bed rest, salt restriction, diuresis, digitalization, vasodilators, &#x3B2;-blockers and anticoagulants.<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B25">25</xref>-<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B36">36</xref>-<xref ref-type="bibr" rid="B42">42</xref>,<xref ref-type="bibr" rid="B51">51</xref> Safety of drugs during pregnancy and lactation should be kept in mind.<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B37">37</xref> Though strict bed rest used to be advised earlier on,<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B38">38</xref> the current recommendation is a gradual increase in activity as tolerated, after the initial distressing symptoms are relieved by drugs, as this has been shown to improve outcome.<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B30">30</xref> Salt and fluid restriction has been advised only in severe PPCM cases.<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B41">41</xref> Digoxin is considered safe during pregnancy and lactation, but patients should be carefully monitored, especially when it is used along with diuretics, because parturients show an increased sensitivity.<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B38">38</xref>,<xref ref-type="bibr" rid="B55">55</xref> Diuretics have been indicated to relieve symptoms of fluid overload.<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B29">29</xref> They are safe when used carefully, but can inadvertently cause hypokalemia and hypovolemia, which may lead to placental hypo-perfusion.<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B36">36</xref> When combined with conventional medical management, spironolactone has been shown to improve outcomes for PPCM patients because of its anti-aldosterone action. However, its safety during pregnancy has yet to be proven.<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B28">28</xref> Vasodilators are now considered vital for a positive outcome in PPCM.<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B28">28</xref> Angiotensin-converting enzyme inhibitors (ACEI) or angiotensin II receptor blockers (ARB) are now a mainstay of congestive cardiomyopathy management.<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B36">36</xref>,<xref ref-type="bibr" rid="B37">37</xref> They are contraindicated during pregnancy because of their teratogenecity; however, they can be considered to treat especially resistant heart failure when the benefit outweigh the risks, or after delivery.<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B37">37</xref> These groups of drugs are excreted in milk and may prevent breast feeding if their use is warranted.<xref ref-type="bibr" rid="B5">5</xref> During the antepartum period, hydralazine, with or without nitrates, is the vasodilator of choice and has been shown to reduce mortality.<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B27">27</xref>-<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B38">38</xref> This is the second tier drug after ACEI/ARB in this regard during the postpartum period.<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B28">28</xref> In severe cases, intravenous nitropruside, nitroglycerin, or nesiritide may be used.<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B37">37</xref>,<xref ref-type="bibr" rid="B41">41</xref> Nitropruside should be avoided during the antepartum period due to the risk of fetal cyanide toxicity.<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B37">37</xref> Calcium channel blockers (CCB) were earlier avoided in heart failure because of their negative inotropic effect;<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B37">37</xref> a few recent studies have shown that amlodipine improves survival and reduces interleukin-6 (IL-6) level in heart failure, indicating a role in management of PPCM patients.<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B37">37</xref> Levosimendan, a calcium sensitizer with vasodilator property, has successfully been used in PPCM patients. This results in the reduction of elevated pulmonary capillary wedge pressure (PCWP) and improvement of ventricular dysfunction, thus allowing for earlier weaning from inotropes.<xref ref-type="bibr" rid="B43">43</xref> Similarly, beta blockers were also initially contraindicated in heart failure patients due to their negative inotropic properties. Recent studies have shown that beta blockers such as carvedilol actually improve outcome.<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B37">37</xref> Although beta blockers are associated with low birth weight babies, they are not absolutely contraindicated in pregnancy.<xref ref-type="bibr" rid="B37">37</xref>,<xref ref-type="bibr" rid="B55">55</xref> Both beta blockers and ACEI have been shown to suppress immune response in patients with PPCM.<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B51">51</xref> This may be beneficial considering the increased evidence for autoimmune etiology.<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B56">56</xref></p>
      <p>Antiarrhythmic agents may be required for control of arrythmias. No antiarrhythmic agent is fully safe in pregnancy. Drugs with the highest safety profiles should be considered first.<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B55">55</xref> Digoxin and &#x3B2;-blockers have been used safely.<xref ref-type="bibr" rid="B55">55</xref> Though amiodarone is toxic during pregnancy, it can be considered in resistant arrhythmias when weighing the risks and benefits.<xref ref-type="bibr" rid="B55">55</xref> Pacemakers and automated implantable cardioverter defibrillators (AICD) are options for refractory and life-threatening arrhythmias for those who have LVEF of less than 25% because of higher incidence of ventricular arrhythmias in this group of patients.<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B37">37</xref>,<xref ref-type="bibr" rid="B51">51</xref>,<xref ref-type="bibr" rid="B55">55</xref></p>
      <p>The incidence of thromboembolism is reported to be very high in PPCM patients having LVEF &lt; 35% and LVFS &lt; 15% with atrial fibrillation,<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B36">36</xref>,<xref ref-type="bibr" rid="B37">37</xref> and patients usually need prophylactic heparin (unfractionated/fractionated) during the antepartum and heparin/warfarin during the post partum period.<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B28">28</xref>-<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B36">36</xref>,<xref ref-type="bibr" rid="B37">37</xref>,<xref ref-type="bibr" rid="B40">40</xref>,<xref ref-type="bibr" rid="B51">51</xref></p>
      <p>Currently, the role of immunosuppressive therapy (azathioprine and prednisolone) in PPCM is controversial,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B37">37</xref> but may be considered for patients not responding to conventional management for two weeks and an endomyocardial biopsy reveals myocarditis.<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B37">37</xref>,<xref ref-type="bibr" rid="B44">44</xref> Even though the role of immunoglobulin has been questioned, it has been used successfully in PPCM.<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B56">56</xref> Considering the increasing evidence of autoimmunity, it can be tried in refractory cases.<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B57">57</xref> Recently, pentoxifylline, an immunomodulating agent, has been shown to improve physical status (NYHA class) and LVEF when added with conventional drugs therapy of PPCM.<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B36">36</xref>,<xref ref-type="bibr" rid="B37">37</xref> Bromocriptine or its congener cabergolin has recently emerged as the causative treatment of PPCM because of emerging evidence of role of 16 kDa fragment of prolactin in the causation of PPCM.<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B46">46</xref>,<xref ref-type="bibr" rid="B52">52</xref> This group of drugs has been shown to improve ventricular dysfunction and to encourage normalization of NT-proBNP, CRP, NYHA class, and LVEF when given to PPCM patients along with standard heart failure therapy, which has shown a real prospect for the etiologic treatment of PPCM.<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B33">33</xref>,<xref ref-type="bibr" rid="B46">46</xref>,<xref ref-type="bibr" rid="B52">52</xref> Routine use of bromocriptine may result in the suppression of lactation, which may deprive the infant of essential nutrition and sometimes cause acute myocardial infarction.<xref ref-type="bibr" rid="B58">58</xref> Moreover, a larger randomized controlled trial is needed to comment firmly on bromocriptine's role in PPCM.<xref ref-type="bibr" rid="B31">31</xref> According to current literature, it may be considered in severe cases.<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B33">33</xref>,<xref ref-type="bibr" rid="B46">46</xref>,<xref ref-type="bibr" rid="B52">52</xref></p>
      <p>Heart transplant is reserved for those young patients resistant to medical treatment with minimal systemic damage.<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B7">7</xref>-<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B35">35</xref>,<xref ref-type="bibr" rid="B37">37</xref>,<xref ref-type="bibr" rid="B40">40</xref>,<xref ref-type="bibr" rid="B59">59</xref> Patients with less than 25% of LVEF end up requiring heart transplant for survival in first or subsequent pregnancies.<xref ref-type="bibr" rid="B17">17</xref> Aggressive measures such as an intra aortic balloon pump (IABP), a ventricular assist device (VAD), veno-atrial bypass, and an extracorporeal membrane oxygenator (ECMO) may be needed in severe cases as a bridging measure for heart transplant.<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B40">40</xref>,<xref ref-type="bibr" rid="B51">51</xref>,<xref ref-type="bibr" rid="B59">59</xref>,<xref ref-type="bibr" rid="B60">60</xref></p>
      <p>PPCM in the antepartum period requires management by a multidisciplinary team consisting of cardiologists, obstetricians and intensivists as the lives of both mother and fetus are at stake.<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B37">37</xref>,<xref ref-type="bibr" rid="B45">45</xref>,<xref ref-type="bibr" rid="B57">57</xref> Induction of labour is considered if patient's condition worsens despite maximal medical management.<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B37">37</xref> Labor analgesia is favored because of its ability to reduce sympathetic stress response of labor pain.<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B42">42</xref>,<xref ref-type="bibr" rid="B61">61</xref>,<xref ref-type="bibr" rid="B62">62</xref> Although a graded epidural is most often used for labor analgesia in PPCM,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B41">41</xref>,<xref ref-type="bibr" rid="B61">61</xref> combined spinal epidural (CSE) and continuous spinal analgesia (CSA) may be better choices (the reasons for this are described later).<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B41">41</xref>,<xref ref-type="bibr" rid="B42">42</xref>,<xref ref-type="bibr" rid="B61">61</xref> Forceps and vacuum devices should be used liberally to reduce the hemodynamic stress of 2nd stage of labour.<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B37">37</xref> Cesarean section is mostly reserved for obstetric indications, but it may be considered in the case of a rapidly decompensating patient where maximum medical therapy fails.<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B37">37</xref>,<xref ref-type="bibr" rid="B45">45</xref>,<xref ref-type="bibr" rid="B57">57</xref> These patients will need to be monitored in the ICU for the initial 2-3 postoperative or post-delivery days due to increased risk of pulmonary edema caused by fluid overload and post-anesthetic cardiac dysfunction.<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B35">35</xref>,<xref ref-type="bibr" rid="B37">37</xref>,<xref ref-type="bibr" rid="B44">44</xref> NYHA class III or IV patients require ICU admission for aggressive management with invasive monitoring, ionotropic, mechanical circulatory and ventilatory support, and ECMO for preoperative optimization.<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B20">20</xref>-<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B37">37</xref>,<xref ref-type="bibr" rid="B41">41</xref>,<xref ref-type="bibr" rid="B60">60</xref>,<xref ref-type="bibr" rid="B62">62</xref> Apart from classical inotropes, inodilators like dobutamine, amrinone, milrinone, enoximone and levosimendan may be beneficial in selective cases.<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B37">37</xref>,<xref ref-type="bibr" rid="B59">59</xref>,<xref ref-type="bibr" rid="B60">60</xref></p>
      <p>Cesarean sections in PPCM patients have been performed under general as well as regional anesthesia.<xref ref-type="bibr" rid="B21">21</xref>-<xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B39">39</xref>,<xref ref-type="bibr" rid="B41">41</xref>,<xref ref-type="bibr" rid="B42">42</xref>,<xref ref-type="bibr" rid="B45">45</xref>,<xref ref-type="bibr" rid="B57">57</xref>,<xref ref-type="bibr" rid="B62">62</xref> General anesthesia is mostly used in emergency surgery or when regional anesthesia is contraindicated,<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B39">39</xref>,<xref ref-type="bibr" rid="B41">41</xref>,<xref ref-type="bibr" rid="B42">42</xref> and it offers the advantage of controlling airway and ventilation.<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B42">42</xref>,<xref ref-type="bibr" rid="B61">61</xref> But, hemodynamic stress from rapid sequence induction can be dangerous if opioids are not used to prevent fetal respiratory depression.<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B42">42</xref> Though both inhalation and intravenous anesthesia have been used in PPCM cases,<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B39">39</xref>,<xref ref-type="bibr" rid="B41">41</xref>,<xref ref-type="bibr" rid="B42">42</xref>,<xref ref-type="bibr" rid="B45">45</xref> both of these techniques can lead to materno-fetal cardiorespiratory adverse effects which may sometimes require naloxone for reversal.<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B39">39</xref>,<xref ref-type="bibr" rid="B41">41</xref>,<xref ref-type="bibr" rid="B42">42</xref> Cardiac arrest following general anaesthesia in PPCM cases is also reported.<xref ref-type="bibr" rid="B39">39</xref>,<xref ref-type="bibr" rid="B41">41</xref> General anaesthesia adds to the already existing risk of thromboembolism.<xref ref-type="bibr" rid="B21">21</xref> Vasodilators may be required to accommodate the extra volume released from uterine autotransfusion after delivery of the fetus to prevent acute cardiac failure and pulmonary edema.<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B26">26</xref></p>
      <p>Regional anesthesia on the other hand can be advantageous in PPCM because of sympatholysis-induced reduction of preload and afterload.<xref ref-type="bibr" rid="B42">42</xref>,<xref ref-type="bibr" rid="B57">57</xref>,<xref ref-type="bibr" rid="B61">61</xref>,<xref ref-type="bibr" rid="B62">62</xref> Single-shot spinal anesthesia is not recommended due to uncontrolled sympathetic blockade and acute hemodynamic instability which may precipitate an adverse cardiac event including arrest.<xref ref-type="bibr" rid="B41">41</xref>,<xref ref-type="bibr" rid="B52">52</xref> Carefully titrated epidural anesthesia has been used in majority of cases because of its hemodynamic stability.<xref ref-type="bibr" rid="B41">41</xref>,<xref ref-type="bibr" rid="B42">42</xref>,<xref ref-type="bibr" rid="B57">57</xref>,<xref ref-type="bibr" rid="B62">62</xref> The major disadvantages of this technique are failure or partial anesthesia which may lead to forced conversion to general anesthesia.<xref ref-type="bibr" rid="B26">26</xref> CSE has been successfully used in patients with PPCM and found to have lower rate of failure, smaller drug requirement, easy titrability with fewer hypotensive episodes (as it can be precisely titrated), faster onset with excellent analgesia, and better patient satisfaction and postoperative pain score.<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B37">37</xref>,<xref ref-type="bibr" rid="B42">42</xref> Other disadvantages such as technical difficulty and post dural puncture headache (PDPH) may rarely be encountered when a 27-gauge pencil point spinal needle is used.<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B61">61</xref> Some anesthesiologists have successfully used continuous spinal anesthesia (CSA) for caesarian section in patients with severe PPCM.<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B61">61</xref> CSA has theoretical advantages over CSE in terms of rapid onset with precise titrability requiring less local anesthetic, but it can be associated with higher incidence of PDPH and neurological complications.<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B37">37</xref>,<xref ref-type="bibr" rid="B41">41</xref>,<xref ref-type="bibr" rid="B61">61</xref> Avoidance of microcatheter and lignocaine has resulted in reduction of these complications.<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B61">61</xref></p>
      <p>Local anesthetic infiltration along with bilateral ilio-inguanal nerve block is a novel technique for cesarean section with minimal hemodynamic effects.<xref ref-type="bibr" rid="B24">24</xref> Unfamiliarity with the technique and higher incidence of failure are major obstacles to its routine implementation,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B26">26</xref> but it can be considered in extreme cases. Although cesarean sections have been successfully conducted in PPCM patients with routine non-invasive monitoring,<xref ref-type="bibr" rid="B62">62</xref> echocardiography and invasive parameters (IBP, CVP and/or PCWP) are usually monitored during anesthesia.<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B39">39</xref>,<xref ref-type="bibr" rid="B41">41</xref>,<xref ref-type="bibr" rid="B42">42</xref>,<xref ref-type="bibr" rid="B45">45</xref>,<xref ref-type="bibr" rid="B57">57</xref>,<xref ref-type="bibr" rid="B60">60</xref>-<xref ref-type="bibr" rid="B62">62</xref> The benefits of invasive and advanced monitoring may outweigh all arguments against it in severe cases.</p>
      <p>Postoperatively, these patients should be routinely monitored in an ICU as they may require a ventilator, inotropic agents, and mechanical circulatory support due to a higher risk of congestive heart failure.<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B21">21</xref>-<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B39">39</xref>,<xref ref-type="bibr" rid="B41">41</xref>,<xref ref-type="bibr" rid="B42">42</xref>,<xref ref-type="bibr" rid="B61">61</xref> Parenteral opioids or regional techniques are used to manage postoperative pain.<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B42">42</xref>,<xref ref-type="bibr" rid="B45">45</xref> Anticoagulant should be restarted early in view of higher risk of thromboembolism.<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B21">21</xref> All preoperative medications should be resumed. Drugs with teratogenic potential such as ACEI/ARBs and warfarin can be safely used after delivery and proper counseling for breast feeding.<xref ref-type="bibr" rid="B37">37</xref></p>
      <p>Prognosis of PPCM is related to presentation as well as to recovery of ventricular dysfunction.<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B11">11</xref> Though about 30-50% recovery of ventricular dysfunction was reported earlier,<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref> currently 60-90% to even complete echocardiographic recovery is reported if LVEF and LVESD on presentation is &#x2265; 27% and &#x2264; 5.5 cm.<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B8">8</xref>-<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B34">34</xref>,<xref ref-type="bibr" rid="B41">41</xref>,<xref ref-type="bibr" rid="B63">63</xref> Basal level of NT-proBNP and IFN-&#x3B3; may be a better predictor in this regard.<xref ref-type="bibr" rid="B49">49</xref> Full recovery is documented by attainment of NYHA class I and LVEF of more than 50%.<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B64">64</xref> This recovery may take 1-2 years, as compared with the classic 6-month time period.<xref ref-type="bibr" rid="B27">27</xref> Those who have persistent LVEF of less than 40% at 3 months or less than 20% at 1-2 months after diagnosis and treatment fail to improve.<xref ref-type="bibr" rid="B51">51</xref> Those with a baseline LVEF of 25% had the worst prognosis and a higher rate of requiring heart transplant for survival.<xref ref-type="bibr" rid="B17">17</xref> This risk was also found not to be modified by subsequent recovery of LVEF after delivery. This specific group of patients may benefit from cardiac MRI, catheterization and endomyocardial biopsy, and may need aphresis, immunoadsorption, intravenous gamma globulin, immunomodulation and antiviral therapy.<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B51">51</xref> Those who do recover have a good survival rate.<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B35">35</xref> Reduction of NT-proBNP and CRP level indicates good recovery of ventricular function. These markers can be monitored to evaluate the prognosis of PPCM.<xref ref-type="bibr" rid="B65">65</xref> The earlier 25-85% mortality rate was reported in patients with persistent or deteriorating cardiac dysfunction,<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B38">38</xref> and the current mortality rate has been reduced to about 0-9% in PPCM cases.<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B7">7</xref>-<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B32">32</xref>,<xref ref-type="bibr" rid="B35">35</xref>,<xref ref-type="bibr" rid="B37">37</xref> The higher mortality in the past was probably due to diagnostic bias and lack of modern heart failure management technology.<xref ref-type="bibr" rid="B20">20</xref> The current trend of improvement is due to advances in medical management.<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B35">35</xref>,<xref ref-type="bibr" rid="B37">37</xref> Comparatively higher mortality (10-30%) and lower rates of recovery of ventricular function (25-35%) have been reported from Africa, Haiti, Turkey and the African-American population in USA.<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B64">64</xref> Race, ethnicity, lack of advanced medical facilities, and lower socioeconomic condition may play a role in this relatively poorer outcome.<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B20">20</xref> A substantial number of these deaths could be prevented with modern medical care.<xref ref-type="bibr" rid="B20">20</xref> Advanced age, multiparity, multiple gestation, African origin, African-American and Hispanic ethnic group, delayed postpartum presentation, coexisting diseases, cardiac thrombus, higher QRS time, LVEDD, LVESD, pulmonary artery pressure, PCWP and reduced LVFS, LVEF, delay in management, higher basal level of NT-proBNP, IFN-&#x3B3;, prolactin, TNF-&#x3B1; have been cited as poor prognostic criteria.<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B49">49</xref></p>
      <p>Recurrence of PPCM in subsequent pregnancies is frequently reported.<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B38">38</xref>,<xref ref-type="bibr" rid="B66">66</xref> PPCM patients with persistent ventricular dysfunction have a higher risk of mortality in future pregnancies.<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B66">66</xref> Fett, et al. found that 46% of patients who had LVEF of less than 55% before pregnancy had a relapse of heart failure in subsequent pregnancies, compared to only 17% relapse of heart failure in those who had LVEF of more than 55% before pregnancy. They suggested that presenting LVEF during pregnancy may an important determinant for relapse of heart failure in subsequent pregnancies.<xref ref-type="bibr" rid="B66">66</xref> It is not fully clear, however, whether patients with improved cardiac function can safely become pregnant again.<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B5">5</xref> There remains the risk of further cardiac damage in subsequent pregnancies.<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B37">37</xref> Recently, one researcher found that even patients whose LVEF was normalized (over 40%) after delivery still had a higher chance of recurrence and worsening heart failure in subsequent pregnancies if the baseline LVEF was less than 25%. Such patients should thus be strongly counseled against future pregnancies.<xref ref-type="bibr" rid="B17">17</xref> Dobutamine stress tests have shown ventricular contractile reserve to be severely impaired in patients showing echocardiographic normalization of cardiac dysfunction.<xref ref-type="bibr" rid="B67">67</xref> Researchers strongly advise against future pregnancies for patients with persistent ventricular dysfunction.<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B37">37</xref> But with currently improved life expectancy and medical management, it may not be always justified to rule out further pregnancy in patients who recover full ventricular function.<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B55">55</xref>,<xref ref-type="bibr" rid="B63">63</xref> If unavoidable, subsequent pregnancies should always be managed by a multidisciplinary approach.<xref ref-type="bibr" rid="B2">2</xref></p>
      <p>Our case report once again supports the recently increasing trend of PPCM in young primigravida. patient's low body weight corroborates the average build of rural Indian population due to malnutrition and poor access to health care. Though cases occurring in last month of pregnancy are included in the classic category of PPCM, cases like ours presenting outside the time range are also categorized as PPCM in literature.<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B21">21</xref>-<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B39">39</xref>,<xref ref-type="bibr" rid="B41">41</xref>,<xref ref-type="bibr" rid="B45">45</xref> The increased hemodynamic load of twin pregnancy with superadded preeclampsia resulted in earlier presentation in our patient. The absence of prior cardiac illness, typical clinical presentation, echocardiographic features, and the persistence of ventricular dysfunction after delivery confirmed the diagnosis of PPCM.<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B4">4</xref> Preeclampsia was diagnosed based on her presenting BP (152/94 mmHg) and proteinuria (grade ++). Her high uric acid level also supported the diagnosis (<xref ref-type="table" rid="T3">Table 3</xref>).<xref ref-type="bibr" rid="B68">68</xref> Co-occurrence of preeclampsia and PPCM has been reported in literature and is usually associated with higher morbidity and mortality.<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B4">4</xref>-<xref ref-type="bibr" rid="B20">20</xref> In our patient, deranged LFT and coagulation parameters caused by the preeclampsia complicated the severe heart failure. The obstetrician ruled out possibility of Hemolysis, Elevated liver enzymes, Low platelet count (HELLP) syndrome, as the laboratory parameters did not fit the classic picture.</p>
      <p>Though termination of pregnancy by cesarean section in PPCM is reserved for obstetric indications, it was done in our patient because of fetal death, rapid worsening of cardiac failure and deteriorating laboratory parameters. A multidisciplinary approach was taken for preoperative optimization with standard management of cardiac failure and correction of coagulation parameters as per literature.<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B37">37</xref>,<xref ref-type="bibr" rid="B42">42</xref> Heparin was not started preoperatively as the patient's coagulation profile was deranged. ACEI was avoided in antepartum period for obvious reasons of teratogenecity.</p>
      <p>We did not preload the patient prior to CSE as we were monitoring the CVP to avoid fluid overload. Although coagulopathy is a relative contraindication for regional anesthesia, the deranged coagulation parameters were corrected and specific precautions were taken as per standard guidelines before performing CSE.<xref ref-type="bibr" rid="B69">69</xref></p>
      <p>A low dosage of intrathecal bupivacaine was used to avoid excessive hypotension and associated complications. We used a slightly higher dosage of intrathecal sufentanil to reduce local anaesthetic requirement and to provide prolonged analgesia, and our patient did not require any epidural top-ups during the surgery.<xref ref-type="bibr" rid="B70">70</xref> This may be advantageous as compared to the use of intrathecal fentanyl, where frequent top ups were required.<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B42">42</xref> This has helped us to avoid epidural-induced hypotension, which would have required vasopressor for management of its adverse consequences in a already cardiac compromised patient.<xref ref-type="bibr" rid="B12">12</xref> Prolonged duration of analgesia seen with neuraxial sufentanil may be because of its higher potency and affinity to opioid receptors.<xref ref-type="bibr" rid="B71">71</xref> No major materno-fetal cardiorespiratory complications occurred, as evidenced by the stable intraoperative vital parameters and the Apgar scores of the fetus. The patient complained of mild itching, which responded appropriately to antihistaminic. Though there are reports of use of intrathecal fentanyl in PPCM patients,<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B42">42</xref> use of sufentanil as an intrathecal opioid for CSE in PPCM patients has not been reported to date. In our patient, subarachonoid block with bupivacaine plus sufentanil was sufficient for operation and resulted in excellent postoperative analgesia for up to six hours. Physiological changes due to severe PPCM might have altered the pharmacokinetics and pharmacodynamics of the spinally administered drugs prolonging their duration of action. Therefore, we feel that sufentanil as an additive in CSE may be more advantageous for anesthesia as well as postoperative pain relief in PPCM patients. More studies are needed to clarify this issue.</p>
      <p>Furosemide was used prophylactically to prevent fluid overload from uterine auto transfusion.<xref ref-type="bibr" rid="B41">41</xref> Vasodilator infusion is also recommended at this stage,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B26">26</xref> but this was not possible in our case because the patient was already on inotropes. There was significant symptomatic improvement after effective onset of the block as seen by the decrease in severity of respiratory symptoms and some improvement in BP as well as SpO<sub>2</sub> due to sympatholysis caused by regional anesthesia establishing its superiority in PPCM.<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B42">42</xref>,<xref ref-type="bibr" rid="B57">57</xref>,<xref ref-type="bibr" rid="B61">61</xref></p>
      <p>Although newer inodilators are more effective for managing biventricular failure,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B41">41</xref> they were not available at our hospital, and a hypotensive state precluded their use. The epidural catheter was removed after the first top up dose under FFP cover as there was a plan to start DVT prophylaxis as soon as the coagulation profile normalized.<xref ref-type="bibr" rid="B69">69</xref> Postoperative pain from cesarean section is not severe from the second postoperative day onwards, and can be managed by conventional analgesics.<xref ref-type="bibr" rid="B26">26</xref></p>
      <p>Dyspnea on the second postoperative day was probably due to volume overload and worsening pathology of PPCM, which was resolved with furosemide and titration of inotropes, confirming our assumption and this was a typical feature of PPCM.<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B39">39</xref> Standard medical management of PPCM was resumed gradually when oral feeding was started. ACEI, spironolactone, carvedilol were added at appropriate time. Although bromocriptine would have been a good choice considering the recent favorable evidence, it was not a good option in this patient due to the concern about depriving the neonate of breast milk.</p>
      <p>Elective termination of pregnancy resulted in improvement in our patient's clinical and laboratory parameters (<xref ref-type="table" rid="T3">Table 3</xref>). However, worsening of her echocardiographic parameters indicates ongoing pathology resulting in persistent postoperative dysfunction. She required insertion of a pacemaker due to persistent bradyarrhythmia, which further supports the higher incidence of malignant arrhythmias in these patients.<xref ref-type="bibr" rid="B20">20</xref> Our case report strengthens the association of bad prognosis in patients with PPCM with multiple gestation, associated preeclampsia presenting with low LVEF and PAH.</p>
      <p>However, as a single patient case report does not carry much scientific weight, we decided to report, as it shows, that CSE approach with sufentanil as a neuraxial opioid can be a safe choice for anesthesia in this delicate subgroup of pregnant patients, if planned properly.</p>
    </sec>
    <sec sec-type="conclusions">
      <title>CONCLUSION</title>
      <p>Anesthetic management of a patient with PPCM should be comprised of adequate preoperative optimization using a multidisciplinary approach, careful monitoring, proper use of anesthetic technique and vigilant postoperative care. Regional anesthesia using CSE with sufentanil may be a good choice for this subgroup of patients.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>ACKNOWLEDGEMENTS</title>
      <p>We are grateful for the help provided by Dr. Somnath Bose and Dr. Mandeep Singh in editing as well as facilitating the acquisition of relevant literature for the preparation of this manuscript.</p>
    </ack>
    <fn-group>
      <fn fn-type="conflict">
        <p>The authors have no financial conflicts of interest.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Demakis</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Rahimtoola</surname>
              <given-names>SH</given-names>
            </name>
          </person-group>
          <article-title>Peripartum cardiomyopathy</article-title>
          <source>Circulation</source>
          <year>1971</year>
          <volume>44</volume>
          <fpage>964</fpage>
          <lpage>968</lpage>
          <pub-id pub-id-type="pmid">4255967</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pearson</surname>
              <given-names>GD</given-names>
            </name>
            <name>
              <surname>Veille</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Rahimtoola</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hsia</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Oakley</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Hosenpud</surname>
              <given-names>JD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Peripartum cardiomyopathy: National Heart, Lung and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendation and review</article-title>
          <source>JAMA</source>
          <year>2000</year>
          <volume>283</volume>
          <fpage>1183</fpage>
          <lpage>1188</lpage>
          <pub-id pub-id-type="pmid">10703781</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hibbard</surname>
              <given-names>JU</given-names>
            </name>
            <name>
              <surname>Lindheimer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lang</surname>
              <given-names>RM</given-names>
            </name>
          </person-group>
          <article-title>A modified definition for peripartum cardiomyopathy and prognosis based on echocardiography</article-title>
          <source>Obstet Gynecol</source>
          <year>1999</year>
          <volume>94</volume>
          <fpage>311</fpage>
          <lpage>316</lpage>
          <pub-id pub-id-type="pmid">10432149</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Demakis</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Rahimtoola</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Sutton</surname>
              <given-names>GC</given-names>
            </name>
            <name>
              <surname>Meadows</surname>
              <given-names>WR</given-names>
            </name>
            <name>
              <surname>Szanto</surname>
              <given-names>PB</given-names>
            </name>
            <name>
              <surname>Tobin</surname>
              <given-names>JR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Natural course of peripartum cardiomyopathy</article-title>
          <source>Circulation</source>
          <year>1971</year>
          <volume>44</volume>
          <fpage>1053</fpage>
          <lpage>1061</lpage>
          <pub-id pub-id-type="pmid">4256828</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bhakta</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Biswas</surname>
              <given-names>BK</given-names>
            </name>
            <name>
              <surname>Banerjee</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Peripartum cardiomyopathy: review of the literature</article-title>
          <source>Yonsei Med J</source>
          <year>2007</year>
          <volume>48</volume>
          <fpage>731</fpage>
          <lpage>747</lpage>
          <pub-id pub-id-type="pmid">17963329</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mayosi</surname>
              <given-names>BM</given-names>
            </name>
          </person-group>
          <article-title>Contemporary trends in the epidemiology and management of cardiomyopathy and pericarditis in sub-Saharan Africa</article-title>
          <source>Heart</source>
          <year>2007</year>
          <volume>93</volume>
          <fpage>1176</fpage>
          <lpage>1183</lpage>
          <pub-id pub-id-type="pmid">17890693</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Midei</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>DeMent</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Feldman</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Hutchins</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Baughman</surname>
              <given-names>KL</given-names>
            </name>
          </person-group>
          <article-title>Peripartum myocarditis and cardiomyopathy</article-title>
          <source>Circulation</source>
          <year>1990</year>
          <volume>81</volume>
          <fpage>922</fpage>
          <lpage>928</lpage>
          <pub-id pub-id-type="pmid">2306840</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ford</surname>
              <given-names>RF</given-names>
            </name>
            <name>
              <surname>Barton</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>O'brien</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Hollingsworth</surname>
              <given-names>PW</given-names>
            </name>
          </person-group>
          <article-title>Demographics, management, and outcome of peripartum cardiomyopathy in a community hospital</article-title>
          <source>Am J Obstet Gynecol</source>
          <year>2000</year>
          <volume>182</volume>
          <fpage>1036</fpage>
          <lpage>1038</lpage>
          <pub-id pub-id-type="pmid">10819820</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Elkayam</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Akhter</surname>
              <given-names>MW</given-names>
            </name>
            <name>
              <surname>Singh</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Khan</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bitar</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Hameed</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation</article-title>
          <source>Circulation</source>
          <year>2005</year>
          <volume>111</volume>
          <fpage>2050</fpage>
          <lpage>2055</lpage>
          <pub-id pub-id-type="pmid">15851613</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Amos</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Jaber</surname>
              <given-names>WA</given-names>
            </name>
            <name>
              <surname>Russell</surname>
              <given-names>SD</given-names>
            </name>
          </person-group>
          <article-title>Improved outcomes in peripartum cardiomyopathy with contemporary</article-title>
          <source>Am Heart J</source>
          <year>2006</year>
          <volume>152</volume>
          <fpage>509</fpage>
          <lpage>513</lpage>
          <pub-id pub-id-type="pmid">16923422</pub-id>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rizeq</surname>
              <given-names>MN</given-names>
            </name>
            <name>
              <surname>Rickenbacher</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Fowler</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Billingham</surname>
              <given-names>ME</given-names>
            </name>
          </person-group>
          <article-title>Incidence of myocarditis in peripartum cardiomyopathy</article-title>
          <source>Am J Cardiol</source>
          <year>1994</year>
          <volume>74</volume>
          <fpage>474</fpage>
          <lpage>477</lpage>
          <pub-id pub-id-type="pmid">8059728</pub-id>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pryn</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bryden</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Reeve</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Patrick</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>McGrady</surname>
              <given-names>EM</given-names>
            </name>
          </person-group>
          <article-title>Cardiomyopathy in pregnancy and caesarean section: four case reports</article-title>
          <source>Int J Obstet Anesth</source>
          <year>2007</year>
          <volume>16</volume>
          <fpage>68</fpage>
          <lpage>73</lpage>
          <pub-id pub-id-type="pmid">17125992</pub-id>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ntusi</surname>
              <given-names>NB</given-names>
            </name>
            <name>
              <surname>Mayosi</surname>
              <given-names>BM</given-names>
            </name>
          </person-group>
          <article-title>Aetiology and risk factors of peripartum cardiomyopathy: a systemic review</article-title>
          <source>Int J Cardiol</source>
          <year>2009</year>
          <volume>131</volume>
          <fpage>168</fpage>
          <lpage>179</lpage>
          <pub-id pub-id-type="pmid">18722678</pub-id>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Modi</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Illum</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Jariatul</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Caldito</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Reddy</surname>
              <given-names>PC</given-names>
            </name>
          </person-group>
          <article-title>Poor outcome of indigent patients with peripartum cardiomyopathy in the United States</article-title>
          <source>Am J Obstet Gynecol</source>
          <year>2009</year>
          <volume>201</volume>
          <fpage>171.e1</fpage>
          <lpage>171.e5</lpage>
          <pub-id pub-id-type="pmid">19564021</pub-id>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mielniczuk</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Lemery</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Green</surname>
              <given-names>MS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Frequency of peripartum cardiomyopathy</article-title>
          <source>Am J Cardiol</source>
          <year>2006</year>
          <volume>97</volume>
          <fpage>1765</fpage>
          <lpage>1768</lpage>
          <pub-id pub-id-type="pmid">16765131</pub-id>
        </element-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gentry</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Dias</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Luis</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Thornton</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Reed</surname>
              <given-names>GL</given-names>
            </name>
          </person-group>
          <article-title>African-American women have a higher risk for developing peripartum cardiomyopathy</article-title>
          <source>J Am Coll Cardiol</source>
          <year>2010</year>
          <volume>55</volume>
          <fpage>654</fpage>
          <lpage>659</lpage>
          <pub-id pub-id-type="pmid">20170791</pub-id>
        </element-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Habli</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>O'Brien</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nowack</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Khoury</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Barton</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Sibai</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Peripartum cardiomyopathy: prognostic factors for long-term maternal outcome</article-title>
          <source>Am J Obstet Gynecol</source>
          <year>2008</year>
          <volume>199</volume>
          <fpage>415.e1</fpage>
          <lpage>415.e5</lpage>
          <pub-id pub-id-type="pmid">18722572</pub-id>
        </element-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Duran</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>G&#xFC;nes</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Duran</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Biteker</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ozkan</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Predictors of prognosis in patients with peripartum cardiomyopathy</article-title>
          <source>Int J Gynaecol Obstet</source>
          <year>2008</year>
          <volume>101</volume>
          <fpage>137</fpage>
          <lpage>140</lpage>
          <pub-id pub-id-type="pmid">18280479</pub-id>
        </element-citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gleicher</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Elkayam</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Peripartum cardiomyopathy, an autoimmune manifestation of allograft rejection?</article-title>
          <source>Autoimmun Rev</source>
          <year>2009</year>
          <volume>8</volume>
          <fpage>384</fpage>
          <lpage>387</lpage>
          <pub-id pub-id-type="pmid">19087892</pub-id>
        </element-citation>
      </ref>
      <ref id="B20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goland</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Modi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Bitar</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Janmohamed</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mirocha</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Czer</surname>
              <given-names>LS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clinical profile and predictors of complications in peripartum cardiomyopathy</article-title>
          <source>J Card Fail</source>
          <year>2009</year>
          <volume>15</volume>
          <fpage>645</fpage>
          <lpage>650</lpage>
          <pub-id pub-id-type="pmid">19786252</pub-id>
        </element-citation>
      </ref>
      <ref id="B21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kaufman</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Bondy</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Benjamin</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Peripartum cardiomyopathy and thromboembolism; anesthetic management and clinical course of an obese, diabetic patient</article-title>
          <source>Can J Anaesth</source>
          <year>2003</year>
          <volume>50</volume>
          <fpage>161</fpage>
          <lpage>165</lpage>
          <pub-id pub-id-type="pmid">12560308</pub-id>
        </element-citation>
      </ref>
      <ref id="B22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zangrillo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Landoni</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Pappalardo</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Oppizzi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Torri</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Different anesthesiological management in two high risk pregnant women with heart failure undergoing emergency cesarean section</article-title>
          <source>Minerva Anestesiol</source>
          <year>2005</year>
          <volume>71</volume>
          <fpage>227</fpage>
          <lpage>236</lpage>
          <pub-id pub-id-type="pmid">15834351</pub-id>
        </element-citation>
      </ref>
      <ref id="B23">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yahagi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kumon</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nakatani</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ishikawa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tanigami</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Eishi</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Peripartum cardiomyopathy and tachycardia followed by multiple organ failure</article-title>
          <source>Anesth Analg</source>
          <year>1994</year>
          <volume>79</volume>
          <fpage>581</fpage>
          <lpage>582</lpage>
          <pub-id pub-id-type="pmid">8067568</pub-id>
        </element-citation>
      </ref>
      <ref id="B24">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mellor</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Bodenham</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Infiltration anesthesia in the management of Cesarean section in a patient with peripartum cardiomyopathy</article-title>
          <source>Anaesthesia</source>
          <year>1996</year>
          <volume>51</volume>
          <fpage>409</fpage>
          <pub-id pub-id-type="pmid">8686850</pub-id>
        </element-citation>
      </ref>
      <ref id="B25">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sliwa</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Fett</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Elkayam</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Peripartum cardiomyopathy</article-title>
          <source>Lancet</source>
          <year>2006</year>
          <volume>368</volume>
          <fpage>687</fpage>
          <lpage>693</lpage>
          <pub-id pub-id-type="pmid">16920474</pub-id>
        </element-citation>
      </ref>
      <ref id="B26">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Velickovic</surname>
              <given-names>IA</given-names>
            </name>
            <name>
              <surname>Leicht</surname>
              <given-names>CH</given-names>
            </name>
          </person-group>
          <article-title>Peripartum cardiomyopathy and cesarean section: report of two cases and literature review</article-title>
          <source>Arch Gynecol Obstet</source>
          <year>2004</year>
          <volume>270</volume>
          <fpage>307</fpage>
          <lpage>310</lpage>
          <pub-id pub-id-type="pmid">14685890</pub-id>
        </element-citation>
      </ref>
      <ref id="B27">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tibazarwa</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sliwa</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Peripartum cardiomyopathy in Africa: challenges in diagnosis, prognosis, and therapy</article-title>
          <source>Prog Cardiovasc Dis</source>
          <year>2010</year>
          <volume>52</volume>
          <fpage>317</fpage>
          <lpage>325</lpage>
          <pub-id pub-id-type="pmid">20109601</pub-id>
        </element-citation>
      </ref>
      <ref id="B28">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Phillips</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Warnes</surname>
              <given-names>CA</given-names>
            </name>
          </person-group>
          <article-title>Peripartum cardiomyopathy: Current Therapeutic Perspectives</article-title>
          <source>Curr Treat Options Cardiovasc Med</source>
          <year>2004</year>
          <volume>6</volume>
          <fpage>481</fpage>
          <lpage>488</lpage>
          <pub-id pub-id-type="pmid">15496265</pub-id>
        </element-citation>
      </ref>
      <ref id="B29">
        <label>29</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Egan</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Bisanzo</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Hutson</surname>
              <given-names>HR</given-names>
            </name>
          </person-group>
          <article-title>Emergency department evaluation and management of peripartum cardiomyopathy</article-title>
          <source>J Emerg Med</source>
          <year>2009</year>
          <volume>36</volume>
          <fpage>141</fpage>
          <lpage>147</lpage>
          <pub-id pub-id-type="pmid">17976813</pub-id>
        </element-citation>
      </ref>
      <ref id="B30">
        <label>30</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moioli</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Valenzano Menada</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bentivoglio</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Ferrero</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Peripartum cardiomyopathy</article-title>
          <source>Arch Gynecol Obstet</source>
          <year>2010</year>
          <volume>281</volume>
          <fpage>183</fpage>
          <lpage>188</lpage>
          <pub-id pub-id-type="pmid">19655159</pub-id>
        </element-citation>
      </ref>
      <ref id="B31">
        <label>31</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ramaraj</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sorrell</surname>
              <given-names>VL</given-names>
            </name>
          </person-group>
          <article-title>Peripartum cardiomyopathy: Causes, diagnosis, and treatment</article-title>
          <source>Cleve Clin J Med</source>
          <year>2009</year>
          <volume>76</volume>
          <fpage>289</fpage>
          <lpage>296</lpage>
          <pub-id pub-id-type="pmid">19414544</pub-id>
        </element-citation>
      </ref>
      <ref id="B32">
        <label>32</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brar</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Khan</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Sandhu</surname>
              <given-names>GK</given-names>
            </name>
            <name>
              <surname>Jorgensen</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Parikh</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Hsu</surname>
              <given-names>JW</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Incidence, mortality, and racial differences in peripartum cardiomyopathy</article-title>
          <source>Am J Cardiol</source>
          <year>2007</year>
          <volume>100</volume>
          <fpage>302</fpage>
          <lpage>304</lpage>
          <pub-id pub-id-type="pmid">17631087</pub-id>
        </element-citation>
      </ref>
      <ref id="B33">
        <label>33</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hilfiker-Kleiner</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Sliwa</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Drexler</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Peripartum cardiomyopathy: recent insight in its pathophysiology</article-title>
          <source>Trends Cardiovasc Med</source>
          <year>2008</year>
          <volume>18</volume>
          <fpage>173</fpage>
          <lpage>179</lpage>
          <pub-id pub-id-type="pmid">18790387</pub-id>
        </element-citation>
      </ref>
      <ref id="B34">
        <label>34</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lamparter</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Pankuweit</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Maisch</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Clinical and immunologic characteristics in peripartum cardiomyopathy</article-title>
          <source>Int J Cardiol</source>
          <year>2007</year>
          <volume>118</volume>
          <fpage>14</fpage>
          <lpage>20</lpage>
          <pub-id pub-id-type="pmid">16904777</pub-id>
        </element-citation>
      </ref>
      <ref id="B35">
        <label>35</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Felker</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Thompson</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Hare</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Hruban</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Clemetson</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>Howard</surname>
              <given-names>DL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Underlying causes and long term survival in patients with initially unexplained cardiomyopathy</article-title>
          <source>N Engl J Med</source>
          <year>2000</year>
          <volume>342</volume>
          <fpage>1077</fpage>
          <lpage>1084</lpage>
          <pub-id pub-id-type="pmid">10760308</pub-id>
        </element-citation>
      </ref>
      <ref id="B36">
        <label>36</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sliwa</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Skudicky</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Bergemann</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Candy</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Puren</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sareli</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/Apo-1</article-title>
          <source>J Am Coll Cardiol</source>
          <year>2000</year>
          <volume>35</volume>
          <fpage>701</fpage>
          <lpage>705</lpage>
          <pub-id pub-id-type="pmid">10716473</pub-id>
        </element-citation>
      </ref>
      <ref id="B37">
        <label>37</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ro</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Frishman</surname>
              <given-names>WH</given-names>
            </name>
          </person-group>
          <article-title>Peripartum cardiomyopathy</article-title>
          <source>Cardiol Rev</source>
          <year>2006</year>
          <volume>14</volume>
          <fpage>35</fpage>
          <lpage>42</lpage>
          <pub-id pub-id-type="pmid">16371764</pub-id>
        </element-citation>
      </ref>
      <ref id="B38">
        <label>38</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burch</surname>
              <given-names>GE</given-names>
            </name>
            <name>
              <surname>McDonald</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Walsh</surname>
              <given-names>JJ</given-names>
            </name>
          </person-group>
          <article-title>The effect of prolonged bed rest on postpartal cardiomyopathy</article-title>
          <source>Am Heart J</source>
          <year>1971</year>
          <volume>81</volume>
          <fpage>186</fpage>
          <lpage>201</lpage>
          <pub-id pub-id-type="pmid">4992772</pub-id>
        </element-citation>
      </ref>
      <ref id="B39">
        <label>39</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McIndoe</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Hammond</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Babington</surname>
              <given-names>PC</given-names>
            </name>
          </person-group>
          <article-title>Peripartum cardiomyopathy presenting as a cardiac arrest at induction of anesthesia for emergency cesarean section</article-title>
          <source>Br J Anaesth</source>
          <year>1995</year>
          <volume>75</volume>
          <fpage>97</fpage>
          <lpage>101</lpage>
          <pub-id pub-id-type="pmid">7669479</pub-id>
        </element-citation>
      </ref>
      <ref id="B40">
        <label>40</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shaikh</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>An obstetric emergency called peripartum cardiomyopathy!</article-title>
          <source>J Emerg Trauma Shock</source>
          <year>2010</year>
          <volume>3</volume>
          <fpage>39</fpage>
          <lpage>42</lpage>
          <pub-id pub-id-type="pmid">20165720</pub-id>
        </element-citation>
      </ref>
      <ref id="B41">
        <label>41</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Malinow</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Butterworth</surname>
              <given-names>JF</given-names>
              <suffix>4th</suffix>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Safon</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Rein</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hartwell</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Peripartum cardiomyopathy presenting at cesarean delivery</article-title>
          <source>Anesthesiology</source>
          <year>1985</year>
          <volume>63</volume>
          <fpage>545</fpage>
          <lpage>547</lpage>
          <pub-id pub-id-type="pmid">4051216</pub-id>
        </element-citation>
      </ref>
      <ref id="B42">
        <label>42</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shnaider</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Ezri</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Szmuk</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Larson</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Warters</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Katz</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Combined spinal-epidural anesthesia for Cesarean section in a patient with peripartum dilated cardiomyopathy</article-title>
          <source>Can J Anaesth</source>
          <year>2001</year>
          <volume>48</volume>
          <fpage>681</fpage>
          <lpage>683</lpage>
          <pub-id pub-id-type="pmid">11495876</pub-id>
        </element-citation>
      </ref>
      <ref id="B43">
        <label>43</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Benezet-Mazuecos</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>de la Hera</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Peripartum cardiomyopathy: a new successful setting for levosimendan</article-title>
          <source>Int J Cardiol</source>
          <year>2008</year>
          <volume>123</volume>
          <fpage>346</fpage>
          <lpage>347</lpage>
          <pub-id pub-id-type="pmid">17324479</pub-id>
        </element-citation>
      </ref>
      <ref id="B44">
        <label>44</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Melvin</surname>
              <given-names>KR</given-names>
            </name>
            <name>
              <surname>Richardson</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Olsen</surname>
              <given-names>EG</given-names>
            </name>
            <name>
              <surname>Daly</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Jackson</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Peripartum cardiomyopathy due to myocarditis</article-title>
          <source>N Engl J Med</source>
          <year>1982</year>
          <volume>307</volume>
          <fpage>731</fpage>
          <lpage>734</lpage>
          <pub-id pub-id-type="pmid">7110225</pub-id>
        </element-citation>
      </ref>
      <ref id="B45">
        <label>45</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bilehjani</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Kianfar</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Toofan</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fakhari</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Anaesthesia with etomidate and remifentanil for cesarean section in a patient with severe peripartum cardiomyopathy--a case report</article-title>
          <source>Middle East J Anesthesiol</source>
          <year>2008</year>
          <volume>19</volume>
          <fpage>1141</fpage>
          <lpage>1149</lpage>
          <pub-id pub-id-type="pmid">18637614</pub-id>
        </element-citation>
      </ref>
      <ref id="B46">
        <label>46</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meyer</surname>
              <given-names>GP</given-names>
            </name>
            <name>
              <surname>Labidi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Podewski</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Sliwa</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Drexler</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hilfiker-Kleiner</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Bromocriptine treatment associated with recovery from peripartum cardiomyopathy in siblings: two case reports</article-title>
          <source>J Med Case Reports</source>
          <year>2010</year>
          <volume>4</volume>
          <fpage>80</fpage>
          <pub-id pub-id-type="pmid">20202212</pub-id>
        </element-citation>
      </ref>
      <ref id="B47">
        <label>47</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reuwer</surname>
              <given-names>AQ</given-names>
            </name>
            <name>
              <surname>Reuwer</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>van der Post</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Cramer</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Kastelein</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Twickler</surname>
              <given-names>MT</given-names>
            </name>
          </person-group>
          <article-title>Prolactin fragmentation by trophoblastic matrix metalloproteinases as a possible contributor to peripartum cardiomyopathy and pre-eclampsia</article-title>
          <source>Med Hypotheses</source>
          <year>2010</year>
          <volume>74</volume>
          <fpage>348</fpage>
          <lpage>352</lpage>
          <pub-id pub-id-type="pmid">19748190</pub-id>
        </element-citation>
      </ref>
      <ref id="B48">
        <label>48</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hilfiker-Kleiner</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Kaminski</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Podewski</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Bonda</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Schaefer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sliwa</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy</article-title>
          <source>Cell</source>
          <year>2007</year>
          <volume>128</volume>
          <fpage>589</fpage>
          <lpage>600</lpage>
          <pub-id pub-id-type="pmid">17289576</pub-id>
        </element-citation>
      </ref>
      <ref id="B49">
        <label>49</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Forster</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Hilfiker-Kleiner</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Ansari</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Sundstrom</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Libhaber</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Tshani</surname>
              <given-names>W</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Reversal of IFN-gamma, oxLDL and prolactin serum levels correlate with clinical improvement in patients with peripartum cardiomyopathy</article-title>
          <source>Eur J Heart Fail</source>
          <year>2008</year>
          <volume>10</volume>
          <fpage>861</fpage>
          <lpage>868</lpage>
          <pub-id pub-id-type="pmid">18768352</pub-id>
        </element-citation>
      </ref>
      <ref id="B50">
        <label>50</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hayakawa</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Chandra</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Miao</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Shirani</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Dorn</surname>
              <given-names>GW</given-names>
              <suffix>2nd</suffix>
            </name>
            <etal/>
          </person-group>
          <article-title>Inhibition of cardiac myocyte apoptosis improves cardiac function and abolishes mortality in the peripartum cardiomyopathy of Galpha(q) transgenic mice</article-title>
          <source>Circulation</source>
          <year>2003</year>
          <volume>108</volume>
          <fpage>3036</fpage>
          <lpage>3041</lpage>
          <pub-id pub-id-type="pmid">14638549</pub-id>
        </element-citation>
      </ref>
      <ref id="B51">
        <label>51</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fett</surname>
              <given-names>JD</given-names>
            </name>
          </person-group>
          <article-title>Understanding peripartum cardiomyopathy, 2008</article-title>
          <source>Int J Cardiol</source>
          <year>2008</year>
          <volume>130</volume>
          <fpage>1</fpage>
          <lpage>2</lpage>
          <pub-id pub-id-type="pmid">18590935</pub-id>
        </element-citation>
      </ref>
      <ref id="B52">
        <label>52</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>de Jong</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Rietveld</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>van Lochem</surname>
              <given-names>LT</given-names>
            </name>
            <name>
              <surname>Bouma</surname>
              <given-names>BJ</given-names>
            </name>
          </person-group>
          <article-title>Rapid left ventricular recovery after cabergoline treatment in a patient with peripartum cardiomyopathy</article-title>
          <source>Eur J Heart Fail</source>
          <year>2009</year>
          <volume>11</volume>
          <fpage>220</fpage>
          <lpage>222</lpage>
          <pub-id pub-id-type="pmid">19168522</pub-id>
        </element-citation>
      </ref>
      <ref id="B53">
        <label>53</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mouquet</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Lions</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>de Groote</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Bouabdallaoui</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Willoteaux</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Dagorn</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Characterisation of peripartum cardiomyopathy by cardiac magnetic resonance imaging</article-title>
          <source>Eur Radiol</source>
          <year>2008</year>
          <volume>18</volume>
          <fpage>2765</fpage>
          <lpage>2769</lpage>
          <pub-id pub-id-type="pmid">18642002</pub-id>
        </element-citation>
      </ref>
      <ref id="B54">
        <label>54</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marmursztejn</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Vignaux</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Goffinet</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Cabanes</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Duboc</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Delayed-enhanced cardiac magnetic resonance imaging features in peripartum cardiomyopathy</article-title>
          <source>Int J Cardiol</source>
          <year>2009</year>
          <volume>137</volume>
          <fpage>e63</fpage>
          <lpage>e64</lpage>
          <pub-id pub-id-type="pmid">19439378</pub-id>
        </element-citation>
      </ref>
      <ref id="B55">
        <label>55</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Page</surname>
              <given-names>RL</given-names>
            </name>
          </person-group>
          <article-title>Treatment of arrhythmias during pregnancy</article-title>
          <source>Am Heart J</source>
          <year>1995</year>
          <volume>130</volume>
          <fpage>871</fpage>
          <lpage>876</lpage>
          <pub-id pub-id-type="pmid">7572599</pub-id>
        </element-citation>
      </ref>
      <ref id="B56">
        <label>56</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bozkurt</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Villaneuva</surname>
              <given-names>FS</given-names>
            </name>
            <name>
              <surname>Holubkov</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Tokarczyk</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Alvarez</surname>
              <given-names>RJ</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>MacGowan</surname>
              <given-names>GA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Intravenous immune globulin in the therapy of peripartum cardiomyopathy</article-title>
          <source>J Am Coll Cardiol</source>
          <year>1999</year>
          <volume>34</volume>
          <fpage>177</fpage>
          <lpage>180</lpage>
          <pub-id pub-id-type="pmid">10400008</pub-id>
        </element-citation>
      </ref>
      <ref id="B57">
        <label>57</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>George</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Gatt</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Lowe</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Peripartum cardiomyopathy: four case histories and a commentary on anaesthetic management</article-title>
          <source>Anaesth Intensive Care</source>
          <year>1997</year>
          <volume>25</volume>
          <fpage>292</fpage>
          <lpage>296</lpage>
          <pub-id pub-id-type="pmid">9209615</pub-id>
        </element-citation>
      </ref>
      <ref id="B58">
        <label>58</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hopp</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Weisse</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Iffy</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Acute myocardial infarction in a healthy mother using bromocriptine for milk suppression</article-title>
          <source>Can J Cardiol</source>
          <year>1996</year>
          <volume>12</volume>
          <fpage>415</fpage>
          <lpage>418</lpage>
          <pub-id pub-id-type="pmid">8608461</pub-id>
        </element-citation>
      </ref>
      <ref id="B59">
        <label>59</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zimmerman</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Bose</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Copeland</surname>
              <given-names>JG</given-names>
            </name>
          </person-group>
          <article-title>Treatment of peripartum cardiomyopathy with mechanical assist devices and cardiac transplantation</article-title>
          <source>Ann Thorac Surg</source>
          <year>2010</year>
          <volume>89</volume>
          <fpage>1211</fpage>
          <lpage>1217</lpage>
          <pub-id pub-id-type="pmid">20338336</pub-id>
        </element-citation>
      </ref>
      <ref id="B60">
        <label>60</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smith</surname>
              <given-names>IJ</given-names>
            </name>
            <name>
              <surname>Gillham</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Fulminant peripartum cardiomyopathy rescue with extracorporeal membranous oxygenation</article-title>
          <source>Int J Obstet Anesth</source>
          <year>2009</year>
          <volume>18</volume>
          <fpage>186</fpage>
          <lpage>188</lpage>
          <pub-id pub-id-type="pmid">19200712</pub-id>
        </element-citation>
      </ref>
      <ref id="B61">
        <label>61</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Okutomi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Saito</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Amano</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Fukuoka</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hoka</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Labour analgesia guided by echocardiography in a parturient with primary dilated cardiomyopathy</article-title>
          <source>Can J Anaesth</source>
          <year>2005</year>
          <volume>52</volume>
          <fpage>622</fpage>
          <lpage>625</lpage>
          <pub-id pub-id-type="pmid">15983149</pub-id>
        </element-citation>
      </ref>
      <ref id="B62">
        <label>62</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gambling</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Flanagan</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Huckell</surname>
              <given-names>VF</given-names>
            </name>
            <name>
              <surname>Lucas</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>JH</given-names>
            </name>
          </person-group>
          <article-title>Anaesthetic management and non-invasive monitoring for caesarean section in a patient with cardiomyopathy</article-title>
          <source>Can J Anaesth</source>
          <year>1987</year>
          <volume>34</volume>
          <fpage>505</fpage>
          <lpage>508</lpage>
          <pub-id pub-id-type="pmid">3664917</pub-id>
        </element-citation>
      </ref>
      <ref id="B63">
        <label>63</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sutton</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Cole</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Plappert</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Saltzman</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Goldhaber</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Effects of subsequent pregnancy on left ventricular function in peripartum cardiomyopathy</article-title>
          <source>Am Heart J</source>
          <year>1991</year>
          <volume>121</volume>
          <fpage>1776</fpage>
          <lpage>1778</lpage>
          <pub-id pub-id-type="pmid">2035390</pub-id>
        </element-citation>
      </ref>
      <ref id="B64">
        <label>64</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fett</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Christie</surname>
              <given-names>LG</given-names>
            </name>
            <name>
              <surname>Carraway</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Murphy</surname>
              <given-names>JG</given-names>
            </name>
          </person-group>
          <article-title>Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution</article-title>
          <source>Mayo Clin Proc</source>
          <year>2005</year>
          <volume>80</volume>
          <fpage>1602</fpage>
          <lpage>1606</lpage>
          <pub-id pub-id-type="pmid">16342653</pub-id>
        </element-citation>
      </ref>
      <ref id="B65">
        <label>65</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>C&#xE9;nac</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tourmen</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Adehossi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Couchouron</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Djibo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Abgrall</surname>
              <given-names>JF</given-names>
            </name>
          </person-group>
          <article-title>The duo low plasma NT-PRO-BRAIN natriuretic peptide and C-reactive protein indicates a complete remission of peripartum cardiomyopathy</article-title>
          <source>Int J Cardiol</source>
          <year>2006</year>
          <volume>108</volume>
          <fpage>269</fpage>
          <lpage>270</lpage>
          <pub-id pub-id-type="pmid">16517283</pub-id>
        </element-citation>
      </ref>
      <ref id="B66">
        <label>66</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fett</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Fristoe</surname>
              <given-names>KL</given-names>
            </name>
            <name>
              <surname>Welsh</surname>
              <given-names>SN</given-names>
            </name>
          </person-group>
          <article-title>Risk of heart failure relapse in subsequent pregnancy among peripartum cardiomyopathy mothers</article-title>
          <source>Int J Gynaecol Obstet</source>
          <year>2010</year>
          <volume>109</volume>
          <fpage>34</fpage>
          <lpage>36</lpage>
          <pub-id pub-id-type="pmid">19945699</pub-id>
        </element-citation>
      </ref>
      <ref id="B67">
        <label>67</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dorbala</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Brozena</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Zeb</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Galatro</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Homel</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Ren</surname>
              <given-names>JF</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Risk stratification of women with peripartum cardiomyopathy at initial presentation: a dobutamine stress echocardiography study</article-title>
          <source>J Am Soc Echocardiogr</source>
          <year>2005</year>
          <volume>18</volume>
          <fpage>45</fpage>
          <lpage>48</lpage>
          <pub-id pub-id-type="pmid">15637488</pub-id>
        </element-citation>
      </ref>
      <ref id="B68">
        <label>68</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Williams</surname>
              <given-names>KP</given-names>
            </name>
            <name>
              <surname>Galerneau</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>The role of serum uric acid as a prognostic indicator of the severity of maternal and fetal complication in hypertensive pregnancies</article-title>
          <source>J Obstet Gynaecol Can</source>
          <year>2002</year>
          <volume>24</volume>
          <fpage>628</fpage>
          <lpage>632</lpage>
          <pub-id pub-id-type="pmid">12196841</pub-id>
        </element-citation>
      </ref>
      <ref id="B69">
        <label>69</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Horlocker</surname>
              <given-names>TT</given-names>
            </name>
            <name>
              <surname>Wedel</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Rowlingson</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Enneking</surname>
              <given-names>FK</given-names>
            </name>
            <name>
              <surname>Kopp</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Benzon</surname>
              <given-names>HT</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition)</article-title>
          <source>Reg Anesth Pain Med</source>
          <year>2010</year>
          <volume>35</volume>
          <fpage>64</fpage>
          <lpage>101</lpage>
          <pub-id pub-id-type="pmid">20052816</pub-id>
        </element-citation>
      </ref>
      <ref id="B70">
        <label>70</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Braga Ade</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Braga</surname>
              <given-names>FS</given-names>
            </name>
            <name>
              <surname>Poterio</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Pereira</surname>
              <given-names>RI</given-names>
            </name>
            <name>
              <surname>Reis</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Cremonesi</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Sufentanil added to hyperbaric bupivacaine for subarachnoid block in Caesarean section</article-title>
          <source>Eur J Anaesthesiol</source>
          <year>2003</year>
          <volume>20</volume>
          <fpage>631</fpage>
          <lpage>635</lpage>
          <pub-id pub-id-type="pmid">12932064</pub-id>
        </element-citation>
      </ref>
      <ref id="B71">
        <label>71</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bachmann-Mennenga</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Veit</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Steinicke</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Biscoping</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Heesen</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Efficacy of sufentanil addition to ropivacaine epidural anaesthesia for Caesarean section</article-title>
          <source>Acta Anaesthesiol Scand</source>
          <year>2005</year>
          <volume>49</volume>
          <fpage>532</fpage>
          <lpage>537</lpage>
          <pub-id pub-id-type="pmid">15777302</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <table-wrap id="T1" position="float">
      <label>Table 1</label>
      <caption>
        <p>Modified Diagnostic Criteria of PPCM<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B3">3</xref></p>
      </caption>
      <graphic xlink:href="ymj-52-1-i001"/>
      <table-wrap-foot>
        <fn>
          <p>LVEF, left ventricular ejection fraction; LVFS, left ventricular fractional shortening; LVEDD, left ventricular end diastolic diameter.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <table-wrap id="T2" position="float">
      <label>Table 2</label>
      <caption>
        <p>Echocardiographic Findings of Peri-Partum Cardiomyopathy</p>
      </caption>
      <graphic xlink:href="ymj-52-1-i002"/>
      <table-wrap-foot>
        <fn>
          <p>MR, mitral regurgitation; TR, tricuspid regurgitation; AR, aortic regurgitation; PAH, pulmonary arterial hypertension; LV, left ventricle; RV, right ventricle; LA, left atrium.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <table-wrap id="T3" position="float">
      <label>Table 3</label>
      <caption>
        <p>Serial Laboratory Investigations and Subsequent Results for the Case Study Patient</p>
      </caption>
      <graphic xlink:href="ymj-52-1-i003"/>
      <table-wrap-foot>
        <fn>
          <p>TLC, total leucocyte count; INR, international normalization ratio; APTT, activated partial thromboplastin time; AST, aspartate amiotransferase; ALT, alanine aminotransferase.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-group>
</article>
</pmc-articleset>
